MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MP-20-0028100
Jyke Pharmaceutical Private Limited
Jyke Pharmaceutical Private Limited - pharma in Gwalior, Madhya Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹1.31 Cr
▲ 2% YoY
Net profit · FY 2025
₹1.43 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹13.17 Lakh
EBITDA margin 10.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹15.13 Lakh
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Jyke Pharmaceutical Private Limited
Data last updated:
Jyke Pharmaceutical Private Limited is a private limited company based in Gwalior, Madhya Pradesh, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 12 December 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24232MP2011PTC027280. Its GSTIN is 23AACCJ7246C1ZX (Madhya Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Jai Prakash Mathur and Sahil Mathur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 71 River View Colony Morar, Gwalior, Madhya Pradesh, India – 474006.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.31 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹1.43 Lakh (net margin 1.1%) and EBITDA of ₹13.17 Lakh (EBITDA margin 10.1%). Revenue has declined at a compounded annual rate (CAGR) of 12% over three years and 4% over five years.
As per MCA filings, the company has open charges of ₹15.13 Lakh on record.
Jyke Pharmaceutical Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MP-20-0028100). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24232MP2011PTC027280
Registration Number 027280
Incorporation Date 12 December 2011
ROC Gwalior
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-MP-20-0028100
Recognitions & Rankings of Jyke Pharmaceutical
Contact details
Jyke Pharmaceutical Private Limited's registered office is in Gwalior, Madhya Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address71 River View Colony Morar, Gwalior, Madhya Pradesh, India – 474006
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Jyke Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
Jyke Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Jyke Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Jyke Pharmaceutical Private Limited, buy the company report.
Financials of Jyke Pharmaceutical Private Limited
FY 2025 filings availableJyke Pharmaceutical Private Limited reported revenue of ₹1.31 Cr (up 2% YoY) for FY 2025.
Revenue · FY 2025
₹1.31 Cr ▲ 2%
Net profit · FY 2025
₹1.43 Lakh margin 1.1%
EBITDA · FY 2025
₹13.17 Lakh margin 10.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 2%
3 years · compounded
▼ 12%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▲ 10%
3 years · compounded
▲ 1%
5 years · compounded
▼ 3%
Revenue rose 2% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA rose 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹13.17 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.43 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 10.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Jyke Pharmaceutical Private Limited, buy the company report.
Board of directors of Jyke Pharmaceutical Private Limited
Jyke Pharmaceutical has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jai Prakash Mathur | Director | 12 Dec 2011 | 14 Years 10 Months | Current |
| Sahil Mathur | Director | 12 Dec 2011 | 14 Years 10 Months | Current |
| Satyendra Kumar Jain | Director | 30 Nov 2016 | 9 Years 10 Months | Current |
Peer comparison
Jyke Pharmaceutical Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Alfa Healthways Private Limited | ₹1.32 Cr (FY 2024) | 2.0% | Pathankot, Punjab, India | |||
| Linco Health Care Private Limited | ₹1.32 Cr (FY 2025) | 91.0% | New Delhi, Delhi, India | |||
| Jyke Pharmaceutical Private Limitedthis company | ₹1.31 Cr (FY 2025) | ₹1.43 Lakh | 1.1% | 2.0% | Gwalior, Madhya Pradesh, India | |
| Hicks Health Care Private Limited | ₹1.31 Cr (FY 2025) | -38.0% | Aligarh, Uttar Pradesh, India | |||
| Swiss Image (India) Private Limited | ₹1.31 Cr (FY 2025) | 228.0% | Delhi, India | |||
| DNPH Technologies Private Limited | ₹1.3 Cr (FY 2025) | -14.0% | Delhi, India | |||
| Kebee Pharmacemie Private Limited | ₹1.3 Cr (FY 2025) | -56.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Jyke Pharmaceutical Private Limited, buy the company report.
Auditor
Jyke Pharmaceutical Private Limited is audited by VIDYARTHI & SONS for the financial year 2016.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| VIDYARTHI & SONS | FY 2016 | 000112C |
Shareholding
The shareholding of Jyke Pharmaceutical Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Jyke Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹15.13 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 29 Oct 2022 | 100674515 | Hdfc Bank Limited | ₹15.13 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Jyke Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Jyke Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Jyke Pharmaceutical has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AACCJ7246C1ZX | Madhya Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Jyke Pharmaceutical Private Limited, buy the company report.
Recent activity
Jyke Pharmaceutical Private Limited has 5 board changes on record since 2011: 4 appointments and 1 cessation. The latest: Neha Mathur ceased to be Director on 30 Nov 2016.
AGM
Jyke Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Jyke Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Gwalior.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.13 Lakh with Charge ID 100674515 was registered on 29 Oct 2022.
Ceased
Neha Mathur ceased to be Director.
Appointed
Satyendra Kumar Jain was appointed as Director.
Appointed
Neha Mathur was appointed as Director.
Appointed
Jai Prakash Mathur was appointed as Director.
Appointed
Sahil Mathur was appointed as Director.
Incorporation
12 Dec 2011
Jyke Pharmaceutical Private Limited was registered on 12 Dec 2011 with Roc Gwalior & aged 14 years 10 months as per MCA records.
Frequently asked questions
Jyke Pharmaceutical is an active private limited company based in Gwalior, Madhya Pradesh, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 12 December 2011 (15+ years old) and is registered under CIN U24232MP2011PTC027280.
Jyke Pharmaceutical has 3 current directors:
- Jai Prakash Mathur - Director
- Sahil Mathur - Director
- Satyendra Kumar Jain - Director
The latest financial statements of Jyke Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Jyke Pharmaceutical is 23AACCJ7246C1ZX, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Jyke Pharmaceutical is U24232MP2011PTC027280. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Jyke Pharmaceutical was incorporated on 12 December 2011, making it 15+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Jyke Pharmaceutical by revenue are Alfa Healthways Private Limited, Linco Health Care Private Limited, Hicks Health Care Private Limited, Swiss Image (India) Private Limited, DNPH Technologies Private Limited and 1 more, all in the Pharma industry (Pharma Retail and Distribution), with the same principal business activity (wholesale trading).
Neha Mathur ceased to be Director on 30 Nov 2016. Satyendra Kumar Jain was appointed as Director on 30 Nov 2016. Neha Mathur was appointed as Director on 21 Jan 2012. Jyke Pharmaceutical has 5 board changes on record in total.
Yes, Jyke Pharmaceutical is registered as a micro enterprise under Udyam registration (number: UDYAM-MP-20-0028100).
The registered office of Jyke Pharmaceutical is at 71 River View Colony Morar, Gwalior, Madhya Pradesh, India – 474006.
Jyke Pharmaceutical operates in the pharma industry, in the pharmaceutical retailers and distributors segment.